hepatocellular carcinoma

miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, Chang-Peng Zhu, Yuan Yang, Wei-Ping Zhou, Jin Ding, Chen-Kai Huang, Ya-Lu Cui, Chen-Hong Ding, Xin Zhang, Bin Lu, Wei-Fen Xie

Gut Jul 2020, 69 (7) 1309-1321; DOI: 10.1136/gutjnl-2019-318830
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation
Sunbin Ling, Qiaonan Shan, Qifan Zhan, Qianwei Ye, Peng Liu, Shengjun Xu, Xin He, Jian Ma, Jiajia Xiang, Guangjiang Jiang, Xue Wen, Zijie Feng, Yuan Wu, Tingting Feng, Li Xu, Kangchen Chen, Xuanyu Zhang, Rongli Wei, Chenzhi Zhang, Beini Cen, Haiyang Xie, Penghong Song, Jimin Liu, Shusen Zheng, Xiao Xu

Gut Jul 2020, 69 (7) 1322-1334; DOI: 10.1136/gutjnl-2019-319616
RSPO2 abnormal transcripts result from read-through in liver tumours with high ß-catenin activation and CTNNB1 mutations
Quentin Bayard, Jean-Charles Nault, Jessica Zucman-Rossi

Gut Jun 2020, 69 (6) 1152-1153; DOI: 10.1136/gutjnl-2019-319089
Are we ready for targeted therapy combinations in HCC?
Einat Cinnamon, Eli Pikarsky

Gut Apr 2020, 69 (4) 613-614; DOI: 10.1136/gutjnl-2019-319780
CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
Cun Wang, Hui Wang, Cor Lieftink, Aimee du Chatinier, Dongmei Gao, Guangzhi Jin, Haojie Jin, Roderick L Beijersbergen, Wenxin Qin, René Bernards

Gut Apr 2020, 69 (4) 727-736; DOI: 10.1136/gutjnl-2019-318506
Adeno-associated virus in the liver: natural history and consequences in tumour development
Tiziana La Bella, Sandrine Imbeaud, Camille Peneau, Iadh Mami, Shalini Datta, Quentin Bayard, Stefano Caruso, Theo Z Hirsch, Julien Calderaro, Guillaume Morcrette, Catherine Guettier, Valerie Paradis, Giuliana Amaddeo, Alexis Laurent, Laurent Possenti, Laurence Chiche, Paulette Bioulac-Sage, Jean-Frederic Blanc, Eric Letouze, Jean-Charles Nault, Jessica Zucman-Rossi

Gut Apr 2020, 69 (4) 737-747; DOI: 10.1136/gutjnl-2019-318281
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Mihnea Paul Dragomir, Scott Kopetz, Jaffer A Ajani, George Adrian Calin

Gut Apr 2020, 69 (4) 748-763; DOI: 10.1136/gutjnl-2019-318279
Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression
Jialing Shen, Mengnuo Chen, Derek Lee, Cheuk-Ting Law, Lai Wei, Felice Ho-Ching Tsang, Don Wai-Ching Chin, Carol Lai-Hung Cheng, Joyce Man-Fong Lee, Irene Oi-Lin Ng, Carmen Chak-Lui Wong, Chun-Ming Wong

Gut Feb 2020, 69 (2) 329-342; DOI: 10.1136/gutjnl-2019-318668
Polyploidy spectrum: a new marker in HCC classification
Myriam Bou-Nader, Stefano Caruso, Romain Donne, Séverine Celton-Morizur, Julien Calderaro, Géraldine Gentric, Mathilde Cadoux, Antoine L’Hermitte, Christophe Klein, Thomas Guilbert, Miguel Albuquerque, Gabrielle Couchy, Valérie Paradis, Jean-Pierre Couty, Jessica Zucman-Rossi, Chantal Desdouets

Gut Feb 2020, 69 (2) 355-364; DOI: 10.1136/gutjnl-2018-318021
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
Man Liu, Jingying Zhou, Xiaoyu Liu, Yu Feng, Weiqin Yang, Feng Wu, Otto Ka-Wing Cheung, Hanyong Sun, Xuezhen Zeng, Wenshu Tang, Myth T S Mok, John Wong, Philip Chun Yeung, Paul Bo San Lai, Zhiwei Chen, Hongchuan Jin, Jie Chen, Stephen Lam Chan, Anthony W H Chan, Ka Fai To, Joseph J Y Sung, Minhu Chen, Alfred Sze-Lok Cheng

Gut Feb 2020, 69 (2) 365-379; DOI: 10.1136/gutjnl-2018-317257

Main menu

hepatocellular carcinoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

hepatocellular carcinoma

Pages